[CRMD] CorMedix Inc

Overview

Type of security: Stock

Sector: Health Care

Industry: Major Pharmaceuticals

Market Capitalization:

Exchange: AMEX

The data is delayed by 15 minutes.

 

Price: 1.75 Change: 0 (0%)
Ext. hours: Change: 0 (0%)

chart CRMD

Refresh chart

Strongest Trends Summary For CRMD

CRMD is in the medium-term down -27% in 2 months and up 358% in 8 months. In the long-term up 3377% in 1 year.

Horizon: 3 hours | 2 days | 5 days | 10 days | 1 month | 6 months | 1 year | 2 years | 5 years | max

Chart type: absolute | relative to S&P

Publish chart

 

Description: CorMedix Inc., a development-stage pharmaceutical and medical device company, intends to in-license, develop, and commercialize therapeutic products for the treatment of cardiorenal and infectious diseases. The company?s product candidates include CRMD003 (Neutrolin) and CRMD004, an antimicrobial/antifungal and anticoagulant combination in liquid and gel formulations used for the prevention of catheter-related blood stream infections and maintenance of catheter patency in hemodialysis patients. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix Inc. in January 2007. CorMedix Inc. was founded in 2006 and is based in Bridgewater, New Jersey.

See how to gain 20% in 14 sec with TrendsInvesting

Fundamental Ratios
Shares Outstanding EPS EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters -22.5% Sales Growth - Q/Q-63.53% P/E
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-94.73% ROE-121.62% ROI
Current Ratio4.57 Quick Ratio4.35 Long Term Debt/Equity Debt Ratio0.28
Gross Margin-83.65% Operating Margin-5512.02% Net Profit Margin-4441.35% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities6.83 M Cash From Investing Activities-10 K Cash From Operating Activities-2.35 M Gross Profit10 K
Net Profit-5.5 M Operating Profit-5.5 M Total Assets9.75 M Total Current Assets9.69 M
Total Current Liabilities2.12 M Total Debt Total Liabilities2.16 M Total Revenue30 K
Technical Data
High 52 week13.25 Low 52 week0.17 Last close7.33 Last change8.75%
RSI37.04 Average true range0.43 Beta0.67 Volume213.35 K
Simple moving average 20 days-4.35% Simple moving average 50 days-13.6% Simple moving average 200 days70.39%
Performance Data
Performance Week-0.41% Performance Month-13.25% Performance Quart-13.25% Performance Half566.36%
Performance Year3377.23% Performance Year-to-date468.22% Volatility daily3.19% Volatility weekly7.14%
Volatility monthly14.63% Volatility yearly50.67% Relative Volume420.72% Average Volume1.17 M
New High New Low

News

2019-06-10 08:30:00 | CorMedix Inc. to Ring NYSE Closing Bell on Monday, June 10

2019-05-16 08:45:00 | CorMedix Inc. to Present at the 20th Annual B. Riley FBR Institutional Investor Conference

2019-05-13 22:28:56 | Edited Transcript of CRMD earnings conference call or presentation 13-May-19 8:30pm GMT

2019-05-13 17:45:09 | CorMedix CRMD Reports Q1 Loss, Tops Revenue Estimates

2019-05-13 16:41:01 | CorMedix: 1Q Earnings Snapshot

2019-05-13 16:05:00 | CorMedix Inc. Reports First Quarter 2019 Financial Results and Provides Business Update

2019-05-10 08:15:00 | Cormedix Announces Presentation of LOCK-IT-100 Study Results at National Kidney Foundation Spring 2019 Meeting

2019-05-08 09:07:01 | Should You Take Comfort From Insider Transactions At CorMedix, Inc. NYSEMKT:CRMD?

2019-05-06 08:15:00 | CorMedix Inc. to Report First Quarter 2019 Financial Results and Provide a Corporate Update on May 13

2019-04-22 08:15:00 | CorMedix Announces Online Pre-Clinical Abstract at the Upcoming Annual Meeting of American Society of Clinical Oncology

2019-04-17 08:00:00 | CorMedix Completes Sale of $5.4 Million of NOL Tax Benefits Through New Jersey Economic Development Authority Program

2019-04-11 16:15:00 | CorMedix Notified of Compliance with NYSE American Listing Requirements

2019-04-02 08:05:54 | Is CorMedix, Inc. NYSEMKT:CRMD Overpaying Its CEO?

2019-03-26 07:36:32 | The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs

2019-03-25 16:15:00 | CorMedix Confirms Previously Announced One-For-Five Reverse Stock Split

2019-03-21 08:30:00 | CorMedix Inc. Announces Appointment of Phoebe Mounts as Executive Vice President and General Counsel

2019-03-14 16:05:00 | CorMedix Inc. Reports Fourth Quarter And Full-Year 2018 Financial Results, Announces Reverse Stock Split And Provides Business Update

2019-03-11 16:35:00 | CorMedix Inc. to Present at Roth and Oppenheimer & Co. Investor Conferences

2019-03-11 10:30:02 | Will CorMedix CRMD Report Negative Q4 Earnings? What You Should Know

2019-03-07 08:00:00 | CorMedix Inc. to Report Year Ended December 31, 2018 Financial Results on Thursday, March 14

2019-03-04 08:00:00 | CorMedix Inc. Appoints Alan W. Dunton, M.D. to Board of Directors

2019-02-21 07:20:00 | Research Report Identifies SS&C Technologies, Allergan plc, CorMedix, The Allstate, Vedanta, and Lexicon Pharmaceuticals with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

2019-02-20 08:00:00 | Biotech Bounce Just Getting Started

2019-02-14 13:47:00 | Here's Why CorMedix Dropped as Much as 27.1% Today

2019-02-14 08:15:00 | CorMedix Inc. Announces FDA Meeting Update

2019-02-13 09:00:00 | Biotech and Cannabis Stocks That Are Emerging

2019-02-12 14:25:00 | These Healthcare Stocks Could Surpass Investor Expectations

2019-01-30 08:15:00 | Cormedix Inc. Announces Topline Analysis of the Full Data Set of Phase 3 Lock-It-100 Study Reinforces the Interim Results

2019-01-29 07:35:00 | Factors of Influence in 2019, Key Indicators and Opportunity within The Hain Celestial Group, Allegheny Technologies, NVR, Greif, CorMedix, and Enzo Biochem — New Research Emphasizes Economic Growth

2019-01-21 08:41:01 | Options Traders Expect Huge Moves in CorMedix CRMD Stock

2019-01-17 09:26:00 | These 4 Healthcare Stocks Are Raising Expectations

2019-01-17 08:00:00 | Cormedix Inc. Announces Highly Statistically Significant Topline Results For NeutrolinR From The Interim Analysis Of The Phase 3 Lock-It-100 Study

2019-01-16 16:15:00 | CorMedix Inc. Announces Resignation of Member of Its Board of Directors

2019-01-16 08:00:00 | Today's Research Reports on Trending Tickers: Incyte and CorMedix

2019-01-09 06:30:00 | This Stock Generated 25X Returns In Just Five Years: Could BTCY Be At The Same Crossroads?

2019-01-03 15:15:00 | Cormedix Announces Closing of $7.5 Million Senior Secured Convertible Debt Financing

2018-12-21 08:58:01 | Implied Volatility Surging for CorMedix CRMD Stock Options

2018-12-11 09:00:00 | CBD and Biotech Plays on The Rise

2018-12-10 15:10:00 | Cormedix Receives Approval to Sell $5.4 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program

2018-11-28 11:50:00 | Biomedical Trends Fuel New Momentum For Healthcare Stocks; Premier Health Group, Inc. OTC: PHGRF CSE: PHGI, Alliqua BioMedical, BioScrip, Coremedix

2018-11-28 08:10:00 | Consolidated Research: 2018 Summary Expectations for Kadmon, Overstock, AECOM, Steelcase, CorMedix, and Corindus Vascular Robotics — Fundamental Analysis, Key Performance Indications

2018-11-27 11:00:00 | CBD and Biotech Stocks to Watch

2018-11-15 15:28:33 | CorMedix: 3Q Earnings Snapshot

2018-11-14 15:10:00 | CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update

2018-11-06 15:00:00 | CorMedix Inc. to Report Third Quarter 2018 Financial Results on Wednesday, November 14

2018-11-02 11:20:00 | 3 Healthcare Stocks Using Technology To Boost Growth

2018-11-01 08:30:00 | Penny Stocks to Buy Using Technical Analysis for November 2018

2018-10-18 09:15:00 | Recent Analysis Shows Lantheus, Editas Medicine, CorMedix, DXP Enterprises, Peabody Energy, and CommScope Holding Market Influences — Renewed Outlook, Key Drivers of Growth

2018-10-18 08:00:00 | CorMedix Inc. Clarifies That No New Shares Are Being Issued In Connection With Its Recently Filed Form S-3 Registration Statement

2018-10-01 07:13:14 | What Kind Of Shareholders Own CorMedix Inc NYSEMKT:CRMD?